LSDF proudly announces awardees for the 2010 Commercialization grant competition. The funded studies will concentrate on improving the success rate of lumbar punctures (spinal taps) in children; developing a safer and more effective magnetic resonance imaging contrast agent; enhancing a DNA sequencing technology to profile T cells within the immune system; and developing a device to detect early stages of tooth decay.
Support for these initiatives comes from - 1. philanthropic funds donated to the LSDF's grant-making activities by Amgen, The Bill & Melinda Gates Foundation, Group Health Cooperative, Microsoft Corp., The Paul G. Allen Family Foundation, Regence BlueShield, and Safeco Insurance Foundation; and 2. Washington's allocation of bonus payments under the Master Tobacco Settlement Agreement (revenues arising from multi-state litigation with tobacco product manufacturers).
Harlan Robins
Eric SeibelLife Sciences Discovery Fund grant awards are subject to specific grant agreement terms and conditions negotiated between the recipient organizations and the Life Sciences Discovery Fund. Awards are contingent pending final grant agreement execution.
Modified: 08/18/10